Pricing Log in Create free account

Oragenics, Inc. (OGEN) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Oragenics, Inc. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Oragenics, Inc. and Purple Biotech Ltd. Sponsored ADR are of similar size ($2.0M and $2.0M). Purple Biotech Ltd. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Across the 10 metrics below, Oragenics, Inc. leads on 5 and Purple Biotech Ltd. Sponsored ADR on 5.

Valuation

Metric OGEN PPBT Biotechnology median
P/E 0.38 n/m 8.50
P/S 15.40 n/m 9.71
P/B 0.52 0.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.16 0.64
EV/Sales 3.56 n/m 9.21
Earnings yield 259.93% (4,315.08%) (33.15%)
Free cash flow yield (534.75%) (643.44%) (25.50%)

Profitability

Metric OGEN PPBT Biotechnology median
Gross margin 19.89% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,307.07%) (110.67%) (56.36%)
Return on assets (264.23%) (100.91%) (48.04%)
Return on invested capital 0.00% (290.25%) 0.00%

Growth

Metric OGEN PPBT Biotechnology median
Revenue growth (TTM) (75.08%) — 6.02%
EPS growth (last fiscal year) 90.51% (10.14%) 30.26%
Revenue growth, 5-year CAGR (50.98%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OGEN PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 3.70 4.72
Net debt to EBITDA 0.98 0.35 0.96

Dividend

Metric OGEN PPBT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OGEN PPBT Biotechnology median
Market cap 1.97m 1.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack